COMP <GO>
SPRY vs CYPH // FREE CASH FLOW YIELD
ARS Pharmaceuticals Inc. (NASDAQ) VS. Cypherpunk Technologies Inc. (NASDAQ) • 15-METRIC TALLY: SPRY 1
— CYPH 3
■ METRIC PARITY
LAST: $3.66 (+0.27%) • MKT CAP: $364.0M
fcf-yield
—
LAST: $3.31 (+2.16%) • MKT CAP: $356.7M
fcf-yield
-12.31%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SPRY VS. CYPH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SPRY | CYPH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -23.30% | -11.70 | CYPH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | — | -12.31% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -5.50% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 3/9 | -1.00 | CYPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.8 | 51.0 | -21.18 | CYPH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 66.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $364.0M | $356.7M | $7.3M | SPRY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SPRY REV | CYPH REV | SPRY GROSS % | CYPH GROSS % | SPRY FCF | CYPH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $84.3M | $0 | — | — | -$171.2M | -$43.9M |
| FY 2024 | $89.1M | $0 | — | — | $13.0M | -$60.3M |
| FY 2023 | $30.0K | $0 | — | — | -$59.3M | -$43.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SPRY // BETA —
CYPH // BETA —